XML 29 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 1,782 $ 1,533
General and administrative 4,514 1,623
Transaction costs 0 5,765
Total operating expenses 6,296 8,921
Loss from operations (6,296) (8,921)
Other expenses, net:    
Loss on sale of NTN assets 0 (9,598)
Warrant liabilities expense (1,322) 0
Loss on non-controlling investment (615) 0
Other expense, net (1,142) (3)
Total other expense, net (3,079) (9,601)
Loss before income taxes (9,375) (18,522)
Provision for income taxes 0 0
Net loss $ (9,375) $ (18,522)
Net loss per common share - basic (in dollars per share) $ (0.17) $ (0.67)
Net loss per common share - diluted (in dollars per share) $ (0.17) $ (0.67)
Weighted average shares outstanding - basic (in shares) 53,626 27,799
Weighted average shares outstanding - diluted (in shares) 53,626 27,799